Index S&P 500
P/E 31.87
EPS (ttm) 2.36
Insider Own 0.46%
Shs Outstand 341.20M
Perf Week 1.85%
Market Cap 25.61B
Forward P/E 17.01
EPS next Y 4.42
Insider Trans -21.22%
Shs Float 338.72M
Perf Month -7.96%
Income 832.90M
PEG 4.19
EPS next Q 0.85
Inst Own 98.36%
Short Float 1.96%
Perf Quarter -2.09%
Sales 6.23B
P/S 4.11
EPS this Y 4.55%
Inst Trans 1.41%
Short Ratio 2.54
Perf Half Y 2.08%
Book/sh 29.86
P/B 2.52
EPS next Y 8.78%
ROA 4.91%
Short Interest 6.65M
Perf Year -11.83%
Cash/sh 2.39
P/C 31.49
EPS next 5Y 7.61%
ROE 8.12%
52W Range 66.15 - 87.10
Perf YTD 0.33%
Dividend Est. 0.32 (0.42%)
P/FCF 18.21
EPS past 5Y 3.68%
ROI 6.10%
52W High -13.61%
Beta 1.12
Dividend TTM 0.32 (0.43%)
Quick Ratio 0.89
Sales past 5Y 6.53%
Gross Margin 59.87%
52W Low 13.76%
ATR (14) 1.59
Dividend Ex-Date Feb 28, 2025
Current Ratio 1.13
EPS Y/Y TTM -2.90%
Oper. Margin 18.44%
RSI (14) 42.81
Volatility 2.00% 1.99%
Employees 18000
Debt/Eq 0.38
Sales Y/Y TTM 2.75%
Profit Margin 13.37%
Recom 2.00
Target Price 90.18
Option/Short Yes / Yes
LT Debt/Eq 0.34
EPS Q/Q -19.80%
Payout 13.55%
Rel Volume 0.65
Prev Close 74.38
Sales Surprise -0.54%
EPS Surprise 4.47%
Sales Q/Q 2.31%
Earnings Feb 07 BMO
Avg Volume 2.62M
Price 75.25
SMA20 -2.38%
SMA50 -4.21%
SMA200 -0.27%
Trades
Volume 1,703,408
Change 1.17%
Date
Action
Analyst
Rating Change
Price Target Change
Dec-09-24 Downgrade
Citigroup
Buy → Neutral
$92 → $86
Nov-18-24 Downgrade
Argus
Buy → Hold
Nov-13-24 Initiated
UBS
Neutral
$84
Oct-10-24 Upgrade
JP Morgan
Neutral → Overweight
$90 → $92
Sep-06-24 Upgrade
Mizuho
Neutral → Outperform
$80 → $90
Sep-06-24 Initiated
Morgan Stanley
Overweight
$89
Sep-06-24 Downgrade
Wolfe Research
Outperform → Peer Perform
Sep-05-24 Upgrade
Raymond James
Mkt Perform → Outperform
Jul-08-24 Upgrade
TD Cowen
Hold → Buy
$75 → $90
Apr-17-24 Downgrade
JP Morgan
Overweight → Neutral
$95 → $90
Mar-14-24 Initiated
Truist
Buy
$99
Jan-02-24 Downgrade
Vertical Research
Buy → Hold
Oct-26-23 Downgrade
BofA Securities
Buy → Neutral
$70
Oct-05-23 Initiated
Exane BNP Paribas
Outperform
$91
Aug-07-23 Initiated
Seaport Research Partners
Buy
$92
Mar-27-23 Upgrade
Vertical Research
Hold → Buy
$74
Oct-12-22 Upgrade
Morgan Stanley
Equal-Weight → Overweight
$68 → $73
Mar-17-22 Upgrade
Argus
Hold → Buy
$68
Mar-14-22 Upgrade
Barclays
Equal Weight → Overweight
$75
Jan-03-22 Downgrade
Vertical Research
Buy → Hold
$82
Show Previous Ratings
Mar-18-25 05:12AM
Mar-11-25 05:03AM
Mar-10-25 09:01AM
Mar-07-25 04:15PM
Mar-05-25 04:01AM
04:15PM
Loading…
Mar-04-25 04:15PM
08:00AM
Feb-28-25 04:06AM
04:04AM
Feb-26-25 07:30AM
Feb-19-25 09:00AM
Feb-12-25 01:59PM
Feb-11-25 04:15PM
04:15PM
Feb-08-25 03:20AM
(Thomson Reuters StreetEvents)
02:10AM
Loading…
02:10AM
Feb-07-25 03:40PM
07:48AM
(Associated Press Finance)
07:38AM
07:30AM
Feb-06-25 11:12PM
08:01AM
Feb-05-25 09:00AM
Jan-29-25 02:02PM
07:30AM
04:03AM
Jan-28-25 04:30PM
Jan-23-25 06:56AM
Jan-14-25 04:03AM
Dec-23-24 04:15PM
04:15PM
Loading…
Dec-16-24 04:15PM
Dec-13-24 04:00AM
Dec-12-24 12:30PM
Dec-11-24 12:41AM
Dec-10-24 09:44AM
Dec-09-24 01:58PM
Dec-05-24 09:00AM
05:00AM
Dec-03-24 09:03AM
Nov-29-24 04:34AM
Nov-08-24 04:15PM
Nov-06-24 04:30PM
Oct-31-24 03:45AM
(Thomson Reuters StreetEvents)
03:14AM
01:57AM
01:07AM
Oct-30-24 10:46AM
07:47AM
07:43AM
(Associated Press Finance)
07:30AM
Oct-29-24 09:00AM
03:53AM
Oct-23-24 10:02AM
Oct-15-24 04:00AM
Oct-10-24 04:00AM
Oct-03-24 11:11AM
05:21AM
Oct-02-24 04:15PM
Sep-23-24 11:14AM
Sep-18-24 09:00AM
Sep-17-24 01:51PM
Sep-16-24 09:00AM
Sep-12-24 04:15PM
01:30AM
Sep-10-24 10:03AM
09:53AM
Sep-05-24 03:19PM
Sep-04-24 07:04PM
06:12PM
(The Wall Street Journal)
04:30PM
Sep-03-24 04:44AM
Aug-30-24 04:30PM
Aug-29-24 04:15PM
Aug-20-24 09:00AM
Aug-19-24 04:23AM
Aug-16-24 03:56AM
Aug-09-24 06:43AM
Aug-05-24 08:29AM
Jul-29-24 07:12AM
Jul-27-24 01:06AM
Jul-26-24 03:28PM
Jul-25-24 10:38AM
Jul-24-24 08:20PM
(Morningstar Research) -8.19%
01:38PM
08:21AM
07:38AM
(Associated Press Finance)
07:30AM
Jul-22-24 09:46AM
Jul-12-24 12:10PM
Jul-09-24 08:20AM
Jul-03-24 07:30AM
06:00AM
Jul-01-24 05:18AM
Jun-27-24 05:10AM
Jun-12-24 08:00AM
Jun-07-24 08:20AM
May-24-24 11:31AM
May-13-24 05:20PM
May-08-24 04:15PM
07:30AM
Fortive Corp. engages in the design, development, manufacturing, and marketing of professional and engineered products, software, and services for a variety of end markets. It operates through the following segments: Intelligent Operating Solutions, Precision Technologies, and Advanced Healthcare Solutions. The Intelligent Operating Solutions segment provides solutions to accelerate industrial and facility reliability and performance, as well as compliance and safety across a range of vertical end markets, including manufacturing, process industries, healthcare, utilities and power, communications, and electronics. The Precision Technologies segment supplies technologies such as electrical test and measurement instruments and services, energetic material devices, and a broad portfolio of sensor and control system solutions. The Advanced Healthcare Solutions segment serves healthcare customers with products and services for critical activities, including instrument and device reprocessing, instrument tracking, cell therapy equipment design and manufacturing, biomedical test tools, radiation safety monitoring, and asset management. The company was founded by James A. Lico and Stacey A. Walker on November 10, 2015 and is headquartered in Everett, WA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Walker Stacey A. SVP - Human Resources Feb 28 '25 Sale 79.05 3,002 237,308 42,373 Mar 04 05:21 PM McLaughlin Charles E SVP - Chief Financial Officer Feb 28 '25 Option Exercise 35.84 16,467 590,177 108,211 Mar 04 05:19 PM McLaughlin Charles E SVP - Chief Financial Officer Feb 28 '25 Sale 78.86 32,085 2,530,223 76,126 Mar 04 05:19 PM Mulhall Christopher M. VP - Chief Accounting Officer Feb 26 '25 Sale 79.95 6,493 519,115 24,283 Feb 28 06:02 PM Mulhall Christopher M. VP - Chief Accounting Officer Feb 26 '25 Sale 80.12 1,395 111,767 5,815 Feb 28 06:02 PM Walker Stacey A. SVP - Human Resources Feb 26 '25 Sale 80.52 5,688 457,998 47,141 Feb 28 06:02 PM Walker Stacey A. Officer Feb 28 '25 Proposed Sale 79.05 3,002 237,302 Feb 28 02:13 PM McLaughlin Charles E Officer Feb 28 '25 Proposed Sale 78.86 32,085 2,530,259 Feb 28 01:24 PM LICO JAMES A President and CEO Feb 24 '25 Option Exercise 35.35 335,999 11,877,853 724,968 Feb 26 07:10 PM LICO JAMES A President and CEO Feb 24 '25 Sale 80.38 196,117 15,763,884 528,851 Feb 26 07:10 PM Walker Stacey A. Officer Feb 26 '25 Proposed Sale 80.52 5,688 457,978 Feb 26 12:01 PM LICO JAMES A Officer Feb 24 '25 Proposed Sale 80.38 196,117 15,763,195 Feb 24 04:19 PM LICO JAMES A Officer Nov 15 '24 Proposed Sale 74.84 80,000 5,986,880 Nov 15 04:58 PM Underwood Peter C SVP - General Counsel Nov 11 '24 Sale 76.58 5,000 382,900 48,346 Nov 13 06:05 PM Underwood Peter C Officer Nov 11 '24 Proposed Sale 76.58 5,000 382,900 Nov 12 10:58 AM Walker Stacey A. SVP - Human Resources Nov 01 '24 Option Exercise 58.03 171,808 9,969,576 214,459 Nov 05 06:21 PM Walker Stacey A. SVP - Human Resources Nov 01 '24 Sale 71.71 171,808 12,320,352 42,651 Nov 05 06:21 PM Walker Stacey A. Officer Nov 01 '24 Proposed Sale 71.71 171,808 12,320,511 Nov 01 02:00 PM McLaughlin Charles E SVP - Chief Financial Officer Sep 13 '24 Sale 74.03 6,864 508,142 73,391 Sep 16 08:09 PM Schwarz Jonathan L SVP - Corporate Development Sep 13 '24 Option Exercise 35.31 14,223 502,214 82,384 Sep 16 08:08 PM Schwarz Jonathan L SVP - Corporate Development Sep 13 '24 Sale 73.80 14,223 1,049,657 68,161 Sep 16 08:08 PM Schwarz Jonathan L Officer Sep 13 '24 Proposed Sale 73.80 14,223 1,049,612 Sep 13 04:41 PM McLaughlin Charles E Officer Sep 13 '24 Proposed Sale 74.03 6,864 508,121 Sep 13 03:27 PM McLaughlin Charles E SVP - Chief Financial Officer Jul 15 '24 Option Exercise 31.75 14,816 470,408 89,828 Jul 16 08:27 PM LICO JAMES A President and CEO May 15 '24 Option Exercise 30.42 29,480 896,782 500,894 May 16 07:37 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite